{
    "address": "Ulls Vag 41",
    "city": "Uppsala",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W8188S100",
    "description": "Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. The company is headquartered in Uppsala, Uppsala and currently employs 15 full-time employees. The company went IPO on 2008-06-18. The firm focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.",
    "employeeTotal": "15.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Health Care",
    "ggroup": "Health Care Equipment & Services",
    "gind": "Health Care Equipment & Supplies",
    "gsector": "Health Care",
    "gsubind": "Health Care Equipment",
    "ipo": "2008-06-18",
    "isin": "SE0002478776",
    "logo": "https://finnhub.io/api/logo?symbol=SEZI.ST",
    "marketCapitalization": 1549.834,
    "naics": "Navigational, Measuring, Electromedical, and Control Instruments Manufacturing",
    "naicsNationalIndustry": "Electromedical and Electrotherapeutic Apparatus Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Computer and Electronic Product Manufacturing",
    "name": "Senzime AB (publ)",
    "phone": "46185156446.0",
    "sedol": "B39QZ26",
    "shareOutstanding": 62.49329,
    "state": "UPPSALA",
    "ticker": "SEZI.ST",
    "weburl": "https://www.senzime.com/"
}